Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: A 98-qubit trapped-ion quantum computer with all-to-all connectivity.

Nature·2026
Same author

Ultrasound targeted fatty acid nitroalkene-containing lipid nanoparticles attenuate inflammation and reverse myocardial fibrosis.

Theranostics·2026
Same author

A 98-qubit trapped-ion quantum computer with all-to-all connectivity.

Nature·2026
Same author

Congenital myasthenic syndrome due to novel <i>GFPT1</i> variant presenting with head drop and visual impairment: A case report.

Journal of neuromuscular diseases·2026
Same author

Case Report: Disulfiram-induced optic neuropathy.

Frontiers in neurology·2026
Same author

Contrast-enhanced ultrasound microbubble uptake and abnormal plasma biomarkers are seen in patients with abdominal aortic aneurysms.

JVS-vascular science·2026

Related Experiment Video

Updated: Jun 20, 2026

Microfluidic Model to Mimic Initial Event of Neovascularization
10:01

Microfluidic Model to Mimic Initial Event of Neovascularization

Published on: April 10, 2021

A novel hydrodynamic method for microvascular flow enhancement.

John J Pacella1, Marina V Kameneva, Linda L Lavery

  • 1Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. pacellajj@upmc.edu

Biorheology
|September 2, 2009
PubMed
Summary
This summary is machine-generated.

Drag-reducing polymers (DRP) improve blood flow by lowering resistance in microvessels. This effect is partly due to vasodilation and also involves unique hydrodynamic changes, offering therapeutic potential for compromised circulation.

More Related Videos

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks
10:53

Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks

Published on: January 3, 2017

Related Experiment Videos

Last Updated: Jun 20, 2026

Microfluidic Model to Mimic Initial Event of Neovascularization
10:01

Microfluidic Model to Mimic Initial Event of Neovascularization

Published on: April 10, 2021

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks
10:53

Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks

Published on: January 3, 2017

Area of Science:

  • Physiology
  • Biomedical Engineering
  • Pharmacology

Background:

  • Microvascular resistance significantly impacts blood flow and tissue perfusion.
  • Stenotic conditions impede blood flow, leading to reduced perfusion.
  • Drag-reducing polymers (DRP) have shown potential in restoring perfusion.

Purpose of the Study:

  • To investigate the mechanisms by which DRP lower microvascular resistance.
  • To determine if DRP-induced resistance lowering is mediated by vasodilation or hydrodynamic changes.
  • To explore the therapeutic potential of DRP in enhancing blood flow.

Main Methods:

  • Intravital microscopy of rat cremaster muscle to assess hemodynamic parameters.
  • Infusion of L-NAME to inhibit nitric oxide-mediated vasodilation.
  • Infusion of adenosine to induce vasodilation prior to DRP administration in rabbit femoral arteries.

Main Results:

  • DRP infusion increased aortic flow, decreased vascular resistance, and increased arteriolar diameter and RBC velocity in rats.
  • L-NAME did not abolish the resistance-lowering effect of DRP.
  • DRP caused additional femoral vascular resistance decrease even after adenosine-induced vasodilation.

Conclusions:

  • DRP enhance microcirculatory perfusion by lowering vascular resistance through both vasodilation and tone-independent hydrodynamic mechanisms.
  • The unique ability of DRP to modulate blood flow hydrodynamics offers therapeutic value for conditions with compromised blood flow.